# MBX Biosciences, Inc.: Form 8-K, filed Jan 12, 2026

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 06:02 ET
- Period: 2026-01-11
- Accession: 0001193125-26-009642
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000119312526009642/mbx-20260111.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000119312526009642/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000119312526009642/mbx-20260111.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-009642. Last ingested by Listed: Nov 10, 2026, 02:04 ET. No prices; not investment advice.